Dr. Jürgen Beck

CMO

Managed clinical development of 6 drugs which have been brought to market (Pirfenidone, Remimazolam, Alfuzosine, Mmisulpride, Mizolastin, Pramipexole)

 

Former CDO at PAION, VP Clin. and Med. Affairs at PROMETH-ERA and VP and Head of Clin Ops at InterMune

 

MD and MBA